Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192055 · ClinicalTrials.gov registry record · NA
Self-sampling to Optimize Anal Lesion Outcomes
A NA study of Anal Cancer, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 572
- Enrollment target
- 3
- Study locations
NCT07192055 is a NA study of Anal Cancer that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 572 participants, roughly in line with the 550-participant average among 19 other Anal Cancer trials with a reported enrollment target. The trial reports 3 study locations across 3 states.
The verdict
NCT07192055, a NA study of Anal Cancer, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 572 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
Conditions Studied
Interventions
- BEHAVIORAL Self-sampling
- OTHER Nylon-flocked Swab
Study Locations (3)
Illinois
- University of Chicago - Chicago
Texas
- The University of Texas M.D. Anderson Cancer Center - Houston
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 572 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07192055
The ClinicalTrials.gov registry entry for NCT07192055 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 572 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 550-participant average among 19 other Anal Cancer trials with a reported enrollment target. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Self-sampling is the first listed.
NCT07192055 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07192055 about?
NCT07192055 is a clinical study titled "Self-sampling to Optimize Anal Lesion Outcomes". The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appo...
What is the current status of trial NCT07192055?
This trial is currently recruiting. It is a NA study. The enrollment target is 572 participants. The study started on 2025-11-18. Estimated completion is 2029-03-31.
What conditions does trial NCT07192055 study?
This clinical trial studies the following conditions: Anal Cancer.
What interventions are being tested in trial NCT07192055?
The interventions under investigation include: Self-sampling (BEHAVIORAL), Nylon-flocked Swab (OTHER).
Who is sponsoring clinical trial NCT07192055?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192055 being conducted?
This trial has 3 study locations across Illinois, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
COMPLETED · NA
-
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
RECRUITING
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
-
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.